Potassium supplementation ameliorates increased plasma homocysteine induced by salt loading in normotensive salt-sensitive subjects

References

• Elliott P, Stamler J, Nichols R, et al. Intersalt revisited: further analyses of 24 hour sodium excretion and BP within and across populations. Intersalt Cooperative Research Group. BMJ 1996;312:1249–1253. doi:10.1136/bmj.312.7041.1249
   Google Scholar
• Poulter NR, Khaw KT, Hopwood BE, et al. The Kenyan Luo migration study: observations on the initiation of a rise in blood pressure. BMJ 1990;300:967–972.
   PubMed Web of Science ®Google Scholar
• Forte JG, Miguel JM, Miguel MJ, et al. Salt and blood pressure: a community trial. J Hum Hypertens 1989;3:179–184.
   PubMed Web of Science ®Google Scholar
• He FJ, MacGregor GA. How far should salt intake be reduced? Hypertension 2003;42:1093–1099. doi: 10.1161/01.HYP.0000102864.05174.E8
   PubMed Web of Science ®Google Scholar
• Morimoto A, Uzu T, Fujii T, et al. Sodium sensitivity and cardiovascular events in patients with essential hypertension. Lancet 1997;350:1734–1737. doi:10.1016/S0140-6736(97)05189-1
   PubMed Web of Science ®Google Scholar
• Weinberger MH, Fineberg NS, Fineberg SE, et al. Salt sensitivity, pulse pressure, and death in normal and hypertensive humans. Hypertension 2001;37:429–432. doi:10.1161/01.HYP.37.2.429
   PubMed Web of Science ®Google Scholar
• D’Elia L, Barba G, Cappuccio FP, et al. Potassium intake, stroke, and cardiovascular disease a meta-analysis of prospective studies. J Am Coll Cardiol 2011;57:1210–19. doi:10.1016/j.jacc.2010.09.070
   PubMed Web of Science ®Google Scholar
• Aburto NJ, Hanson S, Gutierrez H, et al. Effect of increased potassium intake on cardiovascular risk factors and disease: systematic review and meta-analyses. BMJ 2013;346:f1378. doi:10.1136/bmj.f1378
   PubMed Web of Science ®Google Scholar
• Fang Y, Mu JJ, He LC, et al. Salt loading on plasma asymmetrical dimethylarginine and the protective role of potassium supplement in normotensive salt-sensitive Asians. Hypertension 2006;48:724–9. doi: 10.1161/01.HYP.0000238159.19614.ce
   PubMed Web of Science ®Google Scholar
• Glowinska B, Urban M, Koput A, et al. New atherosclerosis risk factors in obese, hypertensive and diabetic children and adolescents. Atherosclerosis 2003;167:275–86. doi:10.1016/S0021-9150(03)00003-0
   PubMed Web of Science ®Google Scholar
• Nygård O, Vollset SE, Refsum H, et al. Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study. JAMA 1995;274:1526–33. doi:10.1001/jama.1995.03530190040032
   Google Scholar
• Stampfer MJ, Malinow MR, Willett WC, et al. A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. JAMA 1992;268:877–81. doi:10.1001/jama.1992.03490070059042
   PubMed Web of Science ®Google Scholar
• Soinio M, Marniemi J, Laakso M, et al. Elevated plasma homocysteine level is an independent predictor of coronary heart disease events in patients with type 2 diabetes mellitus. Ann Intern Med 2004;140:94–100. doi:10.7326/0003-4819-140-2-200401200-00009
   PubMed Web of Science ®Google Scholar
• Tanne D, Haim M, Goldbourt U, et al. Prospective study of serum homocysteine and risk of ischemic stroke among patients with preexisting coronary heart disease. Stroke 2003;34:632–636. doi:10.1161/01.STR.0000060203.58958.35
   PubMed Web of Science ®Google Scholar
• Bostom AG, Rosenberg IH, Silbershatz H, et al. Nonfasting plasma total homocysteine levels and stroke incidence in elderly persons: the Framingham Study. Ann Intern Med 1999;131:352–5. doi:10.7326/0003-4819-131-5-199909070-00006
   PubMed Web of Science ®Google Scholar
• Lange S, Trampisch HJ, Haberl R, et al. Excess 1-year cardiovascular risk in elderly primary care patients with a low ankle-brachial index (ABI) and high homocysteine level. Atherosclerosis 2005;178:351–357. doi:10.1016/j.atherosclerosis.2004.09.003
   PubMed Web of Science ®Google Scholar
• Li N, Chen YF, Zou AP. Implications of hyperhomocysteinemia in glomerular sclerosis in hypertension. Hypertension 2002;39:443–8. doi: 10.1161/hy02t2.102992
   PubMed Web of Science ®Google Scholar
• Chen J, Gu D, Huang J, et al.; GenSalt Collaborative Research Group. GenSalt Collaborative Research Group. Metabolic syndrome and salt sensitivity of blood pressure in non-diabetic people in China: a dietary intervention study. Lancet 2009;373:829–35. doi:10.1016/S0140-6736(09)60144-6
   PubMed Web of Science ®Google Scholar
• Sullivan JM. Salt sensitivity. Definition, conception, methodology, and long-term issues. Hypertension 1991;17(suppl 1):I61–68.
   Google Scholar
• Tousoulis D, Antoniades C, Marinou K, et al. Methionine-loading rapidly impairs endothelial function, by mechanisms independent of endothelin-1: evidence for an association of fasting total homocysteine with plasma endothelin-1 levels. J Am Coll Nutr 2008;27:379–86.
   PubMed Web of Science ®Google Scholar
• Moat SJ, McDowell IF. Homocysteine and endothelial function in human studies. Semin Vasc 2005;5:172–82.
   PubMedGoogle Scholar
• Chiang JK, Sung ML, Yu HR, et al. Homocysteine induces smooth muscle cell proliferation through differential regulation of cyclins A and D1 expression. J Cell Physiol 2011;226:1017–26. doi:10.1002/jcp.22415
   PubMed Web of Science ®Google Scholar
• Miller A, Mujumdar V, Shek E, et al. Hyperhomocyst(e)inemia induces multiorgan damage. Heart Vessels 2000;15:135–43.
   PubMed Web of Science ®Google Scholar
• Kumar M1, Tyagi N, Moshal KS, et al. Homocysteine decreases blood flow to the brain due to vascular resistance in carotid artery. Neurochem Int 2008;53:214–9. doi:10.1016/j.neuint.2008.07.008
   PubMed Web of Science ®Google Scholar
• Li N, Chen L, Muh RW, Li PL. Hyperhomocysteinemia associated with decreased renal transsulfuration activity in Dahl S rats. Hypertension 2006;47:1094–100. doi:10.1161/01.HYP.0000219634.83928.6e
   PubMed Web of Science ®Google Scholar